Exam Pass Notes

Download (Word)

Key Takeaways

• Level 3 safeguarding for clinical pharmacy requires judgement as well as recognition: set thresholds, form a clear risk view, share information lawfully, and record actions so they are defensible.
• Children and young people may show concern through patterns of care, cumulative harm, or professional unease rather than a single disclosure.
• The child's voice must remain central, even when adults dominate the consultation or communication is difficult.
• You do not need proof to act, but you must record clearly, escalate promptly, and understand your role boundaries.
• Local arrangements differ across the UK, so follow your national and organisational safeguarding procedures.

Level 3 Clinical Safeguarding Practice

• Professional curiosity: Notice inconsistent accounts, changing explanations, controlling behaviour, patterns of concern and clinical unease.
• Risk formulation: Identify what increases vulnerability, what may be protective, and where harm is likely to occur.
• Thresholds: Distinguish emerging concern, need for coordinated support, child protection concern, and immediate danger requiring urgent action.
• Role boundaries: Contribute clearly and confidently but do not conduct abuse investigations, undertake forensic work, or promise secrecy.
• Professional challenge: If responses minimise risk or feel inadequate, escalate through the correct channels and document your concerns.

Children, Context, and Higher-Risk Situations

• Development matters: Account for age, developmental stage, disability, trauma, communication needs and neurodivergence when interpreting behaviour and risk.
• Parental and household factors: Domestic abuse, coercive control, parental mental ill-health, substance misuse, household instability and disguised compliance increase safeguarding risk.
• High-risk themes: Abuse, neglect, exploitation, online harm, fabricated or induced illness, trafficking, radicalisation, FGM, forced marriage and honour-based abuse require heightened attention.
• Extra-familial harm: Significant risk can arise from peer groups, relationships, neighbourhoods, transport routes, placements or online spaces as well as the family home.
• Transitions and instability: Children in care, care leavers, missing children and young people moving to adult services are at risk of fragmented care and missed signals.

Responding, Recording, and Sharing

1. Prioritise immediate safety: can the child be moved to safety, and is urgent action required now?
2. Listen calmly, avoid leading questions and record the child's words as accurately as possible.
3. Note what you observed, what you were told, what you checked and what you did; separate fact from professional opinion.
4. Share information lawfully and proportionately to protect the child, even if consent is withheld or cannot safely be sought.
5. Use chronologies, clear summaries and relevant medicines-related evidence to show patterns and changing risk over time.

Clinical Pharmacy Contribution

• Medicines evidence matters: Late prescription collections, missed monitoring, repeated urgent-care presentations and unsafe discharge plans can indicate safeguarding concern.
• Multi-agency contribution: Clinical pharmacy staff can provide medicine-focused evidence to safeguarding leads, paediatrics, social care and child protection processes.
• Pre-birth risk: Treatment instability, poor engagement, domestic abuse, substance misuse and concealed pregnancy can shape pre-birth safeguarding concern.
• Reflective practice: Harm is often missed when information stays fragmented or when professionals assume others hold the full picture.